Trial Profile

A Phase 2a clinical trial assessing TRX01 in people with moderate to severe COVID19

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 17 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Travatrelvir (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

18 Aug 2025 According to Traws Pharma media release, Status changed from planning to recruiting.
18 Aug 2025 According to Traws Pharma media release, company pleased to initiate this Phase 2 trial in the Southern Hemisphere, with top-line data expected by year-end 2025.
15 May 2025 According to Traws Pharma media release, preparations are underway for regulatory briefings and Phase 2 studies.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com